Suppressive effect of oolong tea polymerized polyphenols-enriched oolong tea on postprandial serum triglyceride elevation

Japanese Pharmacology and Therapeutics

Volumn 32, Issue 6, 2004, Pages 335-342

  Hara, Yuji ^a   Moriguchi, Shigeo ^a   Kusumoto, Aki ^a   Nakai, Masaaki ^a   Ono, Yoshiko ^a   Abe, Keiichi ^a   Ohta, Hiromi ^a   Shibata, Hiroshi ^a   Kiso, Yoshinobu ^a   Egawa, Kazutada ^b  

^a SUNTORY LTD   (Japan)

^b Nihonbashi Egawa Clinic   (Japan)

Author keywords

Borderline and mild hyperlipidemia; Oolong tea; Polyphenol; Postprandial serum triglyceride elevation

Indexed keywords

CHOLESTEROL; CHYLOMICRON; PLACEBO; POLYPHENOL; TRIACYLGLYCEROL;

AREA UNDER THE CURVE; ARTICLE; BEVERAGE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; JAPAN; LIPID DIET; MALE; OOLONG TEA; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TEA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 3242749160     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lars sjöström, Aila rissanen, Teis andersen, Mark boldrin, Alain golay, Hans P F koppeschaar, et al. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet 1998; 352 (9123): 167-72.
2. Kagawa K, Matsutaka H, Fukuhara C, Fujino H, Okuda H. Suppressive effect of globin digest on postprandial hyperlipidemia in male volunteers. J Nutr 1988; 128: 56-60.
3. Taguchi H, Watanabe H, Onizawa K, Nagao T, Gotoh N, Yasukawa T, et al. Double-blind controlled study on the effects of dietary diacylglycerol on postprandial serum and chylomicron triacylglycerol responses in healthy humans. J Am Coll Nutr 2000; 19 (6): 789-96.
4. Tada N, Watanabe H, Matsuo N, Tokimitsu I, Okazaki M. Dynamics of postprandial remnant-like lipoprotein particles in serum after loading of diacylglycerol. Clin Chim Acta 2001; 311 (2): 109-17.
5. Kurihara H, Fukami H, Toyoda Y, Kageyama N, Tsuruoka N, Shibata H, et al. Inhibitory effect of oolong tea on the oxidative state of low density lipoprotein (LDL). Biol Pharm Bull 2003; 26 (5): 739-42.
6. Kurihara H, Fukami H, Koda H, Tsuruoka N, Sugiura N, Shibata H, et al. Effects of oolong tea on metabolism of plasma fat in mice under restraint stress. Biosci Biotechnol Biochem 2002; 66 (9): 1955-8.
7. Hosoda K, Wang M, Liao M, Chuang C, Iha M, Bevely C, et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes care 2003; 26 (6): 1714-8.
8. Hashimoto F, Nonaka G, Nishioka I, Tannins and related compounds. XC. 8-C-Ascorbyl (-)-epigallocatechin 3-O-Galltate and novel dimeric flavan-3-ols, oolonghomobisflavans A and B, from oolong tea. (3). Chem Pharm Bull 1989; 37 (12): 3255-63.
9. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999; 246 (4): 341-55.
10. Han LK, Kimura Y, Okuda H. Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int J Obes Relat Metab Disord 1999; 23 (2): 174-9.